| http://www.w3.org/ns/prov#value | - And business has little incentive to invest in the appropriate nanotechnology research targeted at the developing world.Dr Singer explained that this is shown by the lack of new drugs for malaria, dengue fever and other diseases that disproportionately affect people in developing countries.The professor's group in Toronto published a study in 2005 identifying and ranking the 10 nanotechnologies
|
